0000000000300319

AUTHOR

Christian Jacob

showing 15 related works from this author

Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study

2020

Abstract Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study (COMPAS) was a prospective, randomized multicenter clinical trial, comparing methylphenidate (MPH) with placebo (PLAC) in combination with cognitive behavioral group psychotherapy (GPT) or individual clinical management (CM) over the period of 1 year. Here, we report results on treatment safety. Methods MPH and PLAC were flexibly dosed. Among 433 randomized patients, adverse events (AEs) were documented and analyzed on an “as received” basis during week 0–52. Electrocardiogram data were recorded at baseline and week 24. Results Comparing 205 patients who received ≥1 dose of MPH with 209 patients wh…

AdultMaleTachycardiamedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentMedizin610 Medicine & healthPlaceboGroup psychotherapyYoung Adult2738 Psychiatry and Mental Health03 medical and health sciences0302 clinical medicineDouble-Blind MethodInternal medicinemedicinePalpitationsHumans2736 Pharmacology (medical)Pharmacology (medical)Prospective StudiesAdverse effectCognitive Behavioral TherapyHyperhidrosisMethylphenidatebusiness.industryGeneral MedicineMiddle AgedCombined Modality Therapy3. Good health030227 psychiatryClinical trialPsychiatry and Mental healthAttention Deficit Disorder with Hyperactivity10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMethylphenidateCentral Nervous System StimulantsFemalePatient Safetymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugPharmacopsychiatry
researchProduct

Long-term improvement of quality of life in adult ADHD – results of the randomized multimodal COMPAS trial

2021

Attention Deficit Hyperactivity Disorder (ADHD) negatively impacts Quality of Life (QoL) in adults. Earlier studies on pharmacological treatment have shown short-term beneficial effects on QoL. No data are available on long-term effects on multimodal psychosocial and/or pharmacological interventions. The Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS), a prospective, multicenter randomized clinical trial, compared cognitive behavioral group psychotherapy (GPT) with individual clinical management (CM) and methylphenidate (MPH) with placebo (Plac) (2 × 2 factorial design over a period of 52 weeks). Change of QoL was measured after three months of intensive treatme…

medicine.medical_specialtybusiness.industryMethylphenidateHealth PolicyMedizinPublic Health Environmental and Occupational Healthmedicine.diseasehumanities030227 psychiatry3. Good healthPharmacological treatmentTerm (time)03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineQuality of lifemedicineAttention deficit hyperactivity disorderPsychiatrybusinessBeneficial effects030217 neurology & neurosurgerymedicine.drugInternational Journal of Mental Health
researchProduct

Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in a randomized trial

2018

Abstract Background The efficacy of parent-child training (PCT) regarding child symptoms may be reduced if the mother has attention-deficit/hyperactivity disorder (ADHD). The AIMAC study (ADHD in Mothers and Children) aimed to compensate for the deteriorating effect of parental psychopathology by treating the mother (Step 1) before the beginning of PCT (Step 2). This secondary analysis was particularly concerned with the additional effect of the Step 2 PCT on child symptoms after the Step 1 treatment. Methods The analysis included 143 mothers and children (aged 6–12 years) both diagnosed with ADHD. The study design was a two-stage, two-arm parallel group trial (Step 1 treatment group [TG]: …

AdultMalePediatricsmedicine.medical_specialtyEfficacylcsh:RC435-571610Motherslaw.inventionTreatment and control groups03 medical and health sciences0302 clinical medicinePharmacotherapy610 Medical sciences MedicineRandomized controlled trialChild of Impaired ParentslawIntervention (counseling)lcsh:PsychiatryMedicineHumans0501 psychology and cognitive sciencesddc:610ChildChildrenProblem BehaviorPsychiatric Status Rating ScalesPsychotropic Drugsbusiness.industryParent training05 social sciencesTreatment phasesAdult treatmentSequential treatmentCombined Modality Therapy3. Good healthPsychotherapyPsychiatry and Mental healthTreatment OutcomeAttention Deficit Disorder with HyperactivityParent trainingParental psychopathologyFemalebusiness030217 neurology & neurosurgery050104 developmental & child psychologyResearch Article
researchProduct

A multicentre randomized controlled trial on trans-generational attention deficit/hyperactivity disorder (ADHD) in mothers and children (AIMAC): an e…

2018

Abstract. Objective: We examined predictors and moderators of treatment outcome in mothers and children diagnosed with ADHD in a large multicentre RCT. Method: In total, 144 mother-child dyads with ADHD were randomly assigned to either a maternal ADHD treatment (group psychotherapy and open methylphenidate medication, TG) or to a control treatment (individual counselling without psycho- or pharmacotherapy, CG). After maternal ADHD treatment, parent-child training (PCT) for all mother-child dyads was added. The final analysis set was based on 123 dyads with completed primary outcome assessments (TG: n = 67, CG: n = 56). The primary outcome was the change in each child’s externalizing sympto…

Treatment outcomeMotherslaw.inventionTrans generationalRandomized controlled trialChild of Impaired Parentslawmental disordersmedicineAttention deficit hyperactivity disorderHumans0501 psychology and cognitive sciencesChildbusiness.industry05 social sciencesGeneral MedicineExploratory analysismedicine.diseaseModerationPrognosis3. Good healthPsychiatry and Mental healthClinical PsychologyTreatment OutcomeAttention Deficit Disorder with HyperactivityPediatrics Perinatology and Child HealthMethylphenidatePsychotherapy GroupFemalebusiness050104 developmental & child psychologyClinical psychologyZeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie
researchProduct

German validation of the conners adult ADHD rating scale-self-report: confirmation of factor structure in a large sample of participants with ADHD.

2013

Objective: The Conners Adult ADHD Rating Scales (CAARS) assess symptoms specific to adults that are frequently used and have been translated into German. The current study tests the factor structure of the CAARS in a large sample of German adults with ADHD and compares the means of the CAARS subscales with those of healthy German participants. Method: CAARS were completed by 466 participants with ADHD and 851 healthy control participants. Confirmatory factor analysis was used to establish model fit with the American original. Comparisons between participants with ADHD and healthy controls and influences of gender, age, and degree of education were analyzed. Results: Confirmatory factor anal…

AdultMalemedicine.medical_specialtyMedizinFactor structurebehavioral disciplines and activitiesGermanConners Adult ADHD Rating Scales (CAARS)diagnostic issuesRating scaleGermanyHealthy controlmental disordersDevelopmental and Educational Psychologymedicineadult ADHD assessmentADHDHumansddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersPsychiatrySelf reportadult ADHDMiddle AgedConfirmatory factor analysislanguage.human_languageLarge sampleClinical PsychologyAttention Deficit Disorder with HyperactivitylanguageFemaleSelf ReportPsychologyJournal of attention disorders
researchProduct

Fabry Disease With Concomitant Lewy Body Disease

2019

AbstractAlthough Gaucher disease can be accompanied by Lewy pathology (LP) and extrapyramidal symptoms, it is unknown if LP exists in Fabry disease (FD), another progressive multisystem lysosomal storage disorder. We aimed to elucidate the distribution patterns of FD-related inclusions and LP in the brain of a 58-year-old cognitively unimpaired male FD patient suffering from predominant hypokinesia. Immunohistochemistry (CD77, α-synuclein, collagen IV) and neuropathological staging were performed on 100-µm sections. Tissue from the enteric or peripheral nervous system was unavailable. As controls, a second cognitively unimpaired 50-year-old male FD patient without LP or motor symptoms and 3…

complications [Lewy Body Disease]MalePathologyAutopsyDisease0302 clinical medicineHypokinesiapathology [Brain]Lysosomal storage diseasespathology [Neurons]metabolism [alpha-Synuclein]metabolism [Fabry Disease]pathology [Astrocytes]Neuronsα-Synuclein0303 health sciencesParkinsonismTrihexosylceramidesBrainGeneral MedicineMiddle AgedParkinson diseasecomplications [Fabry Disease]Neurologymetabolism [Neurons]alpha-Synucleinmedicine.symptomLewy Body Diseasemedicine.medical_specialtymetabolism [Lewy Body Disease]Context (language use)Substantia nigrametabolism [Trihexosylceramides]Pathology and Forensic Medicineblood supply [Brain]03 medical and health sciencesCellular and Molecular Neuroscienceα-Galactosidase AmedicineHumansddc:610030304 developmental biologypathology [Lewy Bodies]Fabry diseasebusiness.industryPars compactapathology [Lewy Body Disease]Lewy bodies/neuritesOriginal Articlesmetabolism [Lewy Bodies]medicine.diseaseFabry diseasemetabolism [Brain]AstrocytesLewy BodiesNeurology (clinical)CD77pathology [Fabry Disease]business030217 neurology & neurosurgeryJournal of Neuropathology and Experimental Neurology
researchProduct

The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: Further evidence and meta-analysis

2013

NO is a pleiotropic signaling molecule and has an important role in cognition and emotion. In the brain, NO is produced by neuronal nitric oxide synthase (NOS-I, encoded by NOS1) coupled to the NMDA receptor via PDZ interactions; this protein-protein interaction is disrupted upon binding of NOS1 adapter protein (encoded by NOS1AP) to NOS-I. As both NOS1 and NOS1AP were associated with schizophrenia, we here investigated these genes in greater detail by genotyping new samples and conducting a meta-analysis of our own and published data. In doing so, we confirmed association of both genes with schizophrenia and found evidence for their interaction in increasing risk towards disease. Our stron…

NOS1Glutamic AcidNitric Oxide Synthase Type IPolymorphism Single NucleotidePrefrontal cortexNitric oxideAssociationSynapsechemistry.chemical_compoundGlutamatergicSDG 3 - Good Health and Well-beingmedicineAnimalsHumansGenetic Predisposition to DiseasePharmacology (medical)Promoter Regions GeneticPrefrontal cortexBiological PsychiatryAdaptor Proteins Signal TransducingPharmacologyGlutamate receptorComputational BiologyNitric oxideCognitionmedicine.diseasePsychiatry and Mental healthPost-synapseNeurologychemistrySchizophreniaSynapsesRC0321SchizophreniaNeurology (clinical)GlutamatePsychologyRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryNeuroscienceSignal TransductionEuropean Neuropsychopharmacology
researchProduct

The time course of temporal discrimination: An ERP study

2009

Objective: The question of how temporal information is processed by the brain is still a matter of debate. This study aimed to elucidate the brain electrical activity associated with a visual temporal discrimination task. Methods: For this purpose, 44 participants were required to compare pairs of sequentially presented time intervals: a fixed standard interval (1000 ms), and an equal-to-standard, longer (1200 ms) or shorter (800 ms) comparison interval. Behavioural data and event-related potentials (ERPs) were analyzed. Results: Long intervals were more rapidly identified than short intervals. The amplitude of the contingent negative variation (CNV) found at frontocentral sites before the …

AdultMalemedicine.medical_specialtyTime FactorsTime FactorAdolescentVisual time discriminationAudiologyDevelopmental psychologyDiscrimination LearningYoung AdultCognitionMemoryContingent negative variation (CNV)Physiology (medical)medicineHumansEvoked PotentialsTemporal discriminationSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaWorking memoryElectroencephalographyCognitionInterval timingMiddle AgedTemporal LobeSensory SystemsElectrophysiological PhenomenaContingent negative variationElectrophysiologyInterval (music)medicine.anatomical_structureReference memoryNeurologyDuration (music)ScalpEvoked Potentials VisualFemaleNeurology (clinical)Evoked PotentialSensory SystemPsychologyHuman
researchProduct

Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.

2019

Key Points Question What are the long-term results of multimodal treatment for adult attention-deficit/hyperactivity disorder (ADHD) when comparing cognitive behavioral group psychotherapy (GPT) with individual clinical management (CM) in combination with either methylphenidate or placebo? Findings In this follow-up assessment of the Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS), a multicenter randomized clinical trial, 256 adults participated in follow-up 1.5 years after the intervention ended. The severity of ADHD symptoms improved in all 4 prior treatment groups, with no significant difference found between GPT and CM, but methylphenidate was associated wit…

AdultMalemedicine.medical_specialtyRandomizationMedizinPlacebolaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled triallawRating scalemental disordersmedicineAttention deficit hyperactivity disorderHumansYoung adultOriginal InvestigationPsychiatryCognitive Behavioral Therapybusiness.industryResearchBeck Depression InventoryGeneral MedicineMiddle Aged16. Peace & justicemedicine.diseaseCombined Modality Therapy030227 psychiatry3. Good healthOnline OnlyTreatment OutcomeAttention Deficit Disorder with HyperactivityPhysical therapyClinical Global ImpressionMethylphenidateCentral Nervous System StimulantsFemalebusiness030217 neurology & neurosurgeryFollow-Up StudiesJAMA network open
researchProduct

Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder

2008

Contains fulltext : 69243.pdf (Publisher’s version ) (Closed access) Genetic contribution to the development of attention deficit hyperactivity disorder (ADHD) is well established. Seven independent genome-wide linkage scans have been performed to map loci that increase the risk for ADHD. Although significant linkage signals were identified in some of the studies, there has been limited replications between the various independent datasets. The current study gathered the results from all seven of the ADHD linkage scans and performed a Genome Scan Meta Analysis (GSMA) to identify the genomic region with most consistent linkage evidence across the studies. Genome-wide significant linkage (P(S…

Genetics and epigenetic pathways of disease [NCMLS 6]Genetic LinkageEuropean Continental Ancestry GroupMedizinGenome ScanBiologyNeuroinformatics [DCN 3]Mental health [NCEBP 9]Genetic determinismWhite PeopleArticleChromosomesGenomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineGene mappingCognitive neurosciences [UMCN 3.2]Genetic linkageGenetic predispositionmedicinePerception and Action [DCN 1]Attention deficit hyperactivity disorderHumansddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersGenetics (clinical)030304 developmental biologyProbabilityLinkage (software)Genetics0303 health sciencesGenomeGenome HumanPair 16Chromosome Mappingmedicine.diseasePsychiatry and Mental healthGenetic defects of metabolism [UMCN 5.1]Attention Deficit Disorder with HyperactivityMeta-analysisLod ScoreFunctional Neurogenomics [DCN 2]030217 neurology & neurosurgeryChromosomes Human Pair 16HumanAmerican Journal of Medical Genetics. Part B: Neuropsychiatric Genetics
researchProduct

Effectiveness of Psychotherapy in Adult ADHD: What Do Patients Think? Results of the COMPAS Study

2017

Objective: In the multicenter study Comparison of Methylphenidate and Psychotherapy in Adult ADHD (COMPAS), the efficacy of treatments has been primarily evaluated by observer-rated symptom change. Here, we additionally analyzed the patients’ subjective evaluation of therapy effects. Method: COMPAS compared ADHD-specific group therapy with unspecific clinical management with/without concomitant pharmacotherapy in a four-armed design. Evaluation through the patients’ retrospective perspective was performed after 1 year (post-treatment) and after another 1.5 years (follow-up). Results: In respect to patients’ subjective ratings, ADHD-specific group psychotherapy outperformed unspecific manage…

AdultMindfulnessPsychotherapistmedicine.medical_treatmentMedizinGroup psychotherapy03 medical and health sciences0302 clinical medicinePharmacotherapyDevelopmental and Educational PsychologymedicineHumans0501 psychology and cognitive sciencesRetrospective StudiesTherapy EvaluationMethylphenidate05 social sciences3. Good healthClinical PsychologyTreatment OutcomeMulticenter studyAttention Deficit Disorder with HyperactivityConcomitantMethylphenidatePsychotherapy GroupCentral Nervous System StimulantsPsychology030217 neurology & neurosurgery050104 developmental & child psychologyClinical psychologymedicine.drug
researchProduct

German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificity.

2010

AbstractBackgroundThe German version of the Conners Adult ADHD Rating Scales (CAARS) has proven to show very high model fit in confirmative factor analyses with the established factors inattention/memory problems, hyperactivity/restlessness, impulsivity/emotional lability, and problems with self-concept in both large healthy control and ADHD patient samples. This study now presents data on the psychometric properties of the German CAARS-self-report (CAARS-S) and observer-report (CAARS-O) questionnaires.MethodsCAARS-S/O and questions on sociodemographic variables were filled out by 466 patients with ADHD, 847 healthy control subjects that already participated in two prior studies, and a tota…

AdultMalemedicine.medical_specialtyPsychometricsPsychometricsMedizinImpulsivitySensitivity and Specificity03 medical and health sciencesDiagnostic Self Evaluation0302 clinical medicineRating scalemedicineCriterion validityAttention deficit hyperactivity disorderHumans0501 psychology and cognitive sciencesPsychiatryPsychiatric Status Rating ScalesReceiver operating characteristic05 social sciencesDiscriminant validityICD-10Reproducibility of ResultsMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesAttention Deficit Disorder with HyperactivityFemalemedicine.symptomPsychologyFactor Analysis Statistical030217 neurology & neurosurgery050104 developmental & child psychologyClinical psychologyEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder

2015

Importance Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with high prevalence in adulthood. There is a recognized need to assess the efficacy of psychotherapy in adult ADHD. Objective To evaluate the efficacy of cognitive behavioral group psychotherapy (GPT) compared with individual clinical management (CM) and that of methylphenidate hydrochloride compared with placebo. Design, Setting, and Participants Prospective, multicenter, randomized clinical trial of 18- to 58-year-old outpatients with ADHD from 7 German study centers. Patients were recruited between January 2007 and August 2010, treatment was finalized in August 2011, and final follow-up assessmen…

medicine.medical_specialtyPediatricsMethylphenidatemedicine.medical_treatmentMedizinmedicine.diseasePlacebo030227 psychiatry3. Good healthlaw.inventionGroup psychotherapyCognitive behavioral therapy03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineRandomized controlled triallawClinical Global ImpressionmedicineAttention deficit hyperactivity disorderMethylphenidate HydrochloridePsychiatryPsychology030217 neurology & neurosurgerymedicine.drugJAMA Psychiatry
researchProduct

Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multice…

2015

Background This is the first randomized controlled multicenter trial to evaluate the effect of two treatments of maternal attention-deficit hyperactivity disorder (ADHD) on response to parent–child training targeting children's external psychopathology. Methods Mother–child dyads (n = 144; ADHD according to DSM-IV; children: 73.5% males, mean age 9.4 years) from five specialized university outpatient units in Germany were centrally randomized to multimodal maternal ADHD treatment [group psychotherapy plus open methylphenidate medication; treatment group (TG): n = 77] or to clinical management [supportive counseling without psychotherapy or psychopharmacotherapy; control group (CG): n = 67].…

AdultMalePediatricsmedicine.medical_specialtymedicine.medical_treatmentMothersChild Behavior DisordersGroup psychotherapyMaintenance therapyMulticenter trialOutcome Assessment Health CareDevelopmental and Educational PsychologymedicineHumansChildAdverse effectMethylphenidateMiddle AgedCombined Modality TherapyConfidence intervalPsychiatry and Mental healthAttention Deficit Disorder with HyperactivityPediatrics Perinatology and Child HealthMethylphenidatePsychotherapy GroupParent trainingCentral Nervous System StimulantsFamily TherapyFemalePsychologyPsychopathologymedicine.drugClinical psychologyJournal of Child Psychology and Psychiatry
researchProduct

Additional file 1: of Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in …

2018

This article is accompanied by an online supplement containing additional information regarding the analysis. (PDF 376 kb)

researchProduct